TC-325 (HEMOSPRAY™) ALONE IS MORE EFFICACIOUS THAN STANDARD ENDOSCOPIC HEMOSTATIC MODALITIES WHEN MANAGING PATIENTS PRESENTING WITH MALIGNANT GASTROINTESTINAL BLEEDING: META-ANALYSIS OF INDIVIDUAL PATIENT DATA OF RANDOMIZED CONTROLLED STUDIES

Artigo Revisado por pares

TC-325 (HEMOSPRAY™) ALONE IS MORE EFFICACIOUS THAN STANDARD ENDOSCOPIC HEMOSTATIC MODALITIES WHEN MANAGING PATIENTS PRESENTING WITH MALIGNANT GASTROINTESTINAL BLEEDING: META-ANALYSIS OF INDIVIDUAL PATIENT DATA OF RANDOMIZED CONTROLLED STUDIES

2024; Elsevier BV; Volume: 99; Issue: 6 Linguagem: Inglês

10.1016/j.gie.2024.04.1318

ISSN

1097-6779

Autores

Ali Alali, Rapat Pittayanon, Myriam Martel, Bruno da Costa Martins, Majid A. Almadi, Alan Barkun,

Tópico(s)

Esophageal and GI Pathology

Resumo

Kuwait University, Kuwait; Chulalongkorn University, Thailand; Research Institute of the McGill University Health Centre, Canada; Universidade de Sao Paulo Faculdade de Medicina, Brazil; King Khalid University Hospital, Saudi Arabia; McGill University Health Centre, Canada.

Ver no editor

Altmetric

PlumX

Entrar

Lembrar minha senha

Receber meu e-mail de confirmação

TC-325 (HEMOSPRAY™) ALONE IS MORE EFFICACIOUS THAN STANDARD ENDOSCOPIC HEMOSTATIC MODALITIES WHEN MANAGING PATIENTS PRESENTING WITH MALIGNANT GASTROINTESTINAL BLEEDING: META-ANALYSIS OF INDIVIDUAL PATIENT DATA OF RANDOMIZED CONTROLLED STUDIES